"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 4 | 0 | 4 |
| 2012 | 8 | 0 | 8 |
| 2013 | 4 | 0 | 4 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 3 | 1 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students. PLoS One. 2023; 18(1):e0280287.
-
Human Papillomavirus Vaccination Before and During the COVID-19 Pandemic. JAMA Netw Open. 2022 09 01; 5(9):e2234000.
-
Impact of a Virtual Reality Curriculum on Human Papillomavirus Vaccination: A Pilot Trial. Am J Prev Med. 2022 11; 63(5):865-873.
-
The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies. Value Health. 2022 08; 25(8):1336-1343.
-
Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics. Am J Prev Med. 2022 04; 62(4):538-547.
-
Cervical Cancer Screening Guideline for Individuals at Average Risk. JAMA. 2021 Dec 07; 326(21):2193-2194.
-
Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines. Vaccine. 2021 11 05; 39(46):6727-6734.
-
Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers. J Adolesc Young Adult Oncol. 2022 06; 11(3):284-289.
-
Mechanisms of self-persuasion intervention for HPV vaccination: Testing memory and autonomous motivation. Health Psychol. 2021 Dec; 40(12):887-896.
-
Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):656-664.